These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

917 related articles for article (PubMed ID: 25461683)

  • 21. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer.
    Conte C; Marchetti C; Loverro M; Giudice MT; Rosati A; Gallotta V; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2023 Feb; 33(2):137-144. PubMed ID: 36639195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
    van Driel WJ; Koole SN; Sikorska K; Schagen van Leeuwen JH; Schreuder HWR; Hermans RHM; de Hingh IHJT; van der Velden J; Arts HJ; Massuger LFAG; Aalbers AGJ; Verwaal VJ; Kieffer JM; Van de Vijver KK; van Tinteren H; Aaronson NK; Sonke GS
    N Engl J Med; 2018 Jan; 378(3):230-240. PubMed ID: 29342393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
    Durán-Martínez M; Gómez-Dueñas G; Rodriguez-Ortíz L; Sanchez-Hidalgo JM; Gordón-Suárez A; Casado-Adam Á; Rufián-Peña S; Valenzuela-Molina F; Rufián-Andujar B; Vázquez-Borrego MC; Romero-Ruiz A; Briceño-Delgado J; Arjona-Sánchez Á
    Surg Endosc; 2024 Jan; 38(1):66-74. PubMed ID: 37903884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
    Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
    Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis.
    Knisely A; Gamble CR; St Clair CM; Hou JY; Khoury-Collado F; Gockley AA; Wright JD; Melamed A
    J Minim Invasive Gynecol; 2021 Mar; 28(3):537-543. PubMed ID: 33202311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis.
    Arjona-Sanchez A; Esquivel J; Glehen O; Passot G; Turaga KK; Labow D; Rufian-Peña S; Morales R; van der Speeten K
    Surg Endosc; 2019 Mar; 33(3):854-860. PubMed ID: 30003349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
    Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
    Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The robotic future of minimally invasive cytoreduction and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Ortega J; Orfanelli T; Levine E; Konstantinidis IT
    Chin Clin Oncol; 2023 Apr; 12(2):16. PubMed ID: 36946185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer.
    Paik ES; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
    J Gynecol Oncol; 2016 May; 27(3):e24. PubMed ID: 27029745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe?
    Monterossi G; Ghezzi F; Vizza E; Zannoni GF; Uccella S; Corrado G; Restaino S; Quagliozzi L; Casarin J; Dinoi G; Scambia G; Fanfani F
    J Minim Invasive Gynecol; 2017; 24(3):438-445. PubMed ID: 28065812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study.
    Gallotta V; Cicero C; Conte C; Vizzielli G; Petrillo M; Fagotti A; Chiantera V; Costantini B; Scambia G; Ferrandina G
    J Minim Invasive Gynecol; 2017 Feb; 24(2):293-298. PubMed ID: 27856387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back.
    Gueli Alletti S; Vizzielli G; Lafuenti L; Costantini B; Fagotti A; Fedele C; Cianci S; Perrone E; Gallotta V; Rossitto C; Scambia G
    J Minim Invasive Gynecol; 2018; 25(5):816-822. PubMed ID: 29269126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
    Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mininvasive Cytoreduction Surgery plus HIPEC for Epithelial Ovarian Cancer: A Systematic Review.
    Ronsini C; Pasanisi F; Greco P; Cobellis L; De Franciscis P; Cianci S
    Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984422
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience.
    Arjona-Sanchez A; Rufian-Peña S; Sanchez-Hidalgo JM; Casado-Adam A; Cosano-Alvarez A; Briceño-Delgado J
    World J Surg; 2018 Oct; 42(10):3120-3124. PubMed ID: 29691625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later?
    Gonzalez Bayon L; Steiner MA; Vasquez Jimenez W; Asencio JM; Alvarez de Sierra P; Atahualpa Arenas F; Rodriguez del Campo J; Garcia Sabrido JL
    Eur J Surg Oncol; 2013 Oct; 39(10):1109-15. PubMed ID: 23870278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study.
    Ceresoli M; Verrengia A; Montori G; Busci L; Coccolini F; Ansaloni L; Frigerio L
    J Gynecol Oncol; 2018 May; 29(3):e53. PubMed ID: 29533028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study).
    Pomel C; Akladios C; Lambaudie E; Rouzier R; Ferron G; Lecuru F; Classe JM; Fourchotte V; Paillocher N; Wattiez A; Montoriol PF; Thivat E; Beguinot M; Canis M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1572-1578. PubMed ID: 34670829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.